MeSH term
Frequency | Condition_Probility | Animals | 50 | 0.0 |
Cattle | 2 | 0.0 |
Cell Line | 24 | 0.0 |
Cells, Cultured | 12 | 0.0 |
Drug Synergism | 2 | 0.0 |
Humans | 72 | 0.0 |
MAP Kinase Kinase Kinase 3 | 2 | 28.0 |
Research Support, U.S. Gov't, P.H.S. | 31 | 0.0 |
Time Factors | 7 | 0.0 |
Trans-Activation (Genetics)/drug effects | 2 | 0.0 |
Base Sequence | 5 | 0.0 |
Dogs | 5 | 0.0 |
Mice | 27 | 0.0 |
Mice, Knockout | 3 | 0.0 |
Morphogenesis/*physiology | 2 | 20.0 |
Phosphorylation | 44 | 0.0 |
Proto-Oncogene Protein c-met/*physiology | 3 | 27.0 |
Recombinant Fusion Proteins/metabolism | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 61 | 0.0 |
Transfection | 21 | 0.0 |
Amino Acid Sequence | 14 | 0.0 |
CHO Cells | 2 | 0.0 |
Enzyme Activation/drug effects | 8 | 0.0 |
Gene Expression Regulation | 5 | 0.0 |
Hamsters | 4 | 0.0 |
Insulin/pharmacology | 2 | 0.0 |
Mitogen-Activated Protein Kinase 3 | 5 | 0.0 |
Mitogen-Activated Protein Kinases/*metabolism | 5 | 0.0 |
Molecular Sequence Data | 13 | 0.0 |
Mutagenesis, Site-Directed | 6 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 6 | 0.0 |
Proto-Oncogene Proteins/metabolism | 8 | 0.0 |
*Drosophila Proteins | 3 | 0.0 |
Gene Expression | 3 | 0.0 |
Phosphoproteins/*physiology | 6 | 7.0 |
Signal Transduction/physiology | 2 | 0.0 |
Tyrosine/metabolism | 18 | 1.0 |
1-Phosphatidylinositol 3-Kinase/*metabolism | 10 | 3.0 |
Blotting, Western | 10 | 0.0 |
Enzyme Inhibitors/pharmacology | 10 | 0.0 |
Glutathione Transferase/metabolism | 6 | 0.0 |
Helminth Proteins/metabolism | 2 | 16.0 |
Nitriles/pharmacology | 2 | 1.0 |
Phosphoproteins/*metabolism | 11 | 2.0 |
Precipitin Tests | 11 | 0.0 |
Protein Binding | 18 | 0.0 |
Protein Structure, Tertiary | 13 | 0.0 |
Signal Transduction | 21 | 0.0 |
src Homology Domains | 15 | 2.0 |
*Adaptor Proteins, Signal Transducing | 16 | 1.0 |
COS Cells | 8 | 0.0 |
Enzyme Activation | 16 | 0.0 |
MAP Kinase Kinase 1 | 2 | 1.0 |
MAP Kinase Signaling System/*physiology | 2 | 2.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 4 | 1.0 |
Mitogen-Activated Protein Kinase Kinases/metabolism | 2 | 1.0 |
Phosphoproteins/physiology | 4 | 6.0 |
Proteins/metabolism | 7 | 0.0 |
src-Family Kinases/metabolism | 2 | 1.0 |
Amino Acid Motifs | 7 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Phosphoproteins/chemistry/genetics/*metabolism | 5 | 12.0 |
Rats | 4 | 0.0 |
Receptor, Macrophage Colony-Stimulating Factor/metabolism | 2 | 25.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Apoptosis | 3 | 0.0 |
Binding Sites | 15 | 0.0 |
Cell Line, Tumor | 3 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Dose-Response Relationship, Drug | 5 | 0.0 |
Immunoblotting | 3 | 0.0 |
Immunoprecipitation | 2 | 0.0 |
Microscopy, Fluorescence | 4 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 11 | 1.0 |
Models, Biological | 6 | 0.0 |
Models, Genetic | 3 | 0.0 |
Mutation | 9 | 0.0 |
NIH 3T3 Cells | 2 | 0.0 |
Plasmids/metabolism | 3 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 4 | 0.0 |
Receptor Protein-Tyrosine Kinases/*metabolism | 2 | 0.0 |
Retroviridae/genetics | 2 | 0.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 17 | 3.0 |
3T3 Cells | 5 | 0.0 |
DNA/metabolism | 4 | 0.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 6 | 0.0 |
Proteins/*metabolism | 5 | 0.0 |
Comparative Study | 3 | 0.0 |
1-Phosphatidylinositol 3-Kinase/*physiology | 2 | 3.0 |
Androstadienes/pharmacology | 5 | 1.0 |
Chromones/pharmacology | 4 | 1.0 |
Flavonoids/pharmacology | 3 | 0.0 |
Morpholines/pharmacology | 4 | 1.0 |
Phosphoproteins/chemistry/*metabolism | 2 | 3.0 |
*Adaptor Proteins, Vesicular Transport | 4 | 1.0 |
Antigens, CD/*metabolism | 2 | 0.0 |
Phosphoric Monoester Hydrolases/metabolism | 2 | 2.0 |
Protein-Tyrosine-Phosphatase/metabolism | 10 | 8.0 |
Receptors, Antigen, B-Cell/*metabolism | 2 | 2.0 |
Cell Division | 8 | 0.0 |
Cell Movement | 3 | 0.0 |
*Signal Transduction | 10 | 0.0 |
Cell Survival | 3 | 0.0 |
Hepatocyte Growth Factor/*metabolism | 2 | 1.0 |
Proto-Oncogene Protein c-met/*metabolism | 6 | 10.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Phosphoproteins/genetics/*metabolism/physiology | 2 | 33.0 |
Receptor, Epidermal Growth Factor/*metabolism | 4 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Tumor Cells, Cultured | 17 | 0.0 |
Phosphorylation/drug effects | 3 | 0.0 |
Protein Processing, Post-Translational | 2 | 0.0 |
Phosphoproteins/metabolism/*physiology | 3 | 17.0 |
*Protein-Serine-Threonine Kinases | 8 | 0.0 |
Rabbits | 4 | 0.0 |
Signal Transduction/drug effects/physiology | 2 | 0.0 |
Cercopithecus aethiops | 5 | 0.0 |
Proteins/genetics/*metabolism | 2 | 0.0 |
Proto-Oncogene Proteins/genetics/metabolism | 2 | 1.0 |
Receptor Protein-Tyrosine Kinases/genetics/*metabolism | 2 | 1.0 |
*src Homology Domains | 2 | 1.0 |
Phosphoproteins/genetics/*metabolism | 10 | 6.0 |
Point Mutation | 2 | 0.0 |
Cell Communication | 2 | 0.0 |
Female | 3 | 0.0 |
Hepatocyte Growth Factor/pharmacology | 2 | 3.0 |
Isoenzymes/metabolism | 2 | 0.0 |
Disease Progression | 2 | 0.0 |
Hela Cells | 8 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Jurkat Cells | 2 | 0.0 |
Phosphoproteins/metabolism | 9 | 1.0 |
Tyrosine/chemistry | 2 | 1.0 |
Up-Regulation | 2 | 0.0 |
Receptor, Epidermal Growth Factor/*physiology | 2 | 1.0 |
Receptor, erbB-2/physiology | 2 | 25.0 |
Cell Adhesion/physiology | 2 | 0.0 |
Cell Division/physiology | 2 | 0.0 |
Male | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Signal Transduction/*physiology | 4 | 0.0 |
Hepatocyte Growth Factor/*pharmacology | 2 | 1.0 |
Brain/metabolism | 2 | 0.0 |
Cell Adhesion | 2 | 0.0 |
Phosphotyrosine/metabolism | 7 | 1.0 |
Proto-Oncogene Protein c-met/genetics/*metabolism | 2 | 11.0 |
Phosphoric Monoester Hydrolases/*metabolism | 2 | 2.0 |
Proto-Oncogene Protein c-kit/metabolism | 2 | 4.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism | 3 | 0.0 |
Cytokines/*physiology | 2 | 1.0 |
Kinetics | 3 | 0.0 |
*Nerve Growth Factors | 2 | 1.0 |
ras Proteins/metabolism | 3 | 1.0 |
JNK Mitogen-Activated Protein Kinases | 5 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Trans-Activators/metabolism | 2 | 0.0 |
Peptides/chemistry | 2 | 0.0 |
Receptors, Antigen, B-Cell/*physiology | 2 | 2.0 |
Enhancer Elements (Genetics) | 2 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
*DNA-Binding Proteins | 2 | 0.0 |
*Proto-Oncogene Proteins | 3 | 0.0 |
Receptor, Epidermal Growth Factor/metabolism | 3 | 0.0 |
Molecular Weight | 2 | 0.0 |
Protein-Tyrosine-Phosphatase/*metabolism | 3 | 2.0 |
Proto-Oncogene Proteins/physiology | 2 | 1.0 |
Mutagenesis | 3 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
Structure-Activity Relationship | 4 | 0.0 |
Receptor, erbB-2/*physiology | 2 | 8.0 |
Immunosorbent Techniques | 2 | 0.0 |
Receptor, Insulin/*metabolism | 2 | 3.0 |
Phosphoproteins/genetics/*physiology | 2 | 5.0 |
Blotting, Northern | 2 | 0.0 |
Cell Transformation, Neoplastic | 2 | 0.0 |
Recombinant Proteins/genetics/metabolism | 2 | 0.0 |
Epidermal Growth Factor/pharmacology | 3 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Protein-Tyrosine-Phosphatase/genetics/*metabolism | 2 | 4.0 |
Recombinant Fusion Proteins | 2 | 0.0 |
Green Fluorescent Proteins | 2 | 0.0 |
Ligands | 2 | 0.0 |
